Adverse reactions to ezetimibe may include rhabdomyolysis, hypersensitivity reactions, and pancreatitis, but the exact severity varies from person to person and cannot be stated as a whole.
Ezetimibe can lower blood cholesterol levels and can be used in combination with dietary control and statins as an adjunctive treatment for primary hypercholesterolemia, pure steroidemia (or phytosterolemia), and pure familial hypercholesterolemia.
A variety of adverse reactions may occur during treatment with the drug, commonly abdominal pain, diarrhea, gastrointestinal gas and bloating, fatigue, elevated aminotransferases, headache, myalgia, malaise, peripheral edema, etc. Patients may also experience adverse reactions such as pancreatitis, erythema multiforme, hypersensitivity reactions, rhabdomyolysis, myopathy, and other adverse reactions.
The drug needs to be contraindicated in patients with active liver disease, those with unexplained persistent elevation of serum aminotransferases, those who are allergic to the product and its components. It should not be used by pregnant and lactating women.
The occurrence of adverse reactions varies from person to person, and the type and severity of adverse reactions vary, so it is not possible to determine the specific type of serious adverse reactions to the drug.
The drug should be used in accordance with medical advice.